19 November 2017
News and Views
Links and Services
A team of doctors developed a framework for measuring symptoms in the irritable bowel syndrome, reports the most recent issue of the Alimentary Pharmacology & Therapeutics.
There is uncertainty about how to measure patient-reported outcomes in IBS. The Food and Drug Adm
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors